Ramadan begins in Mangaluru, Udupi; no taraveeh in mosques

Bengaluru, Apr 20: Former chief minister HD Kumaraswamy, reacting to the incident which happened in Padarayanapura area of the city last night, in which a group of men vandalised a police barricade, said that the perpetrators of the violence should be dealt with severely.

He further said, "It was not at all needed to attack Asha workers, police or doctors. These kinds of incidents are not acceptable. It is an act of shame. It does not matter which community the perpetrators belong to, each and everyone must follow the guidelines and law. Whoever indulged in such an act must be punished."

Earlier on Sunday, a ruckus erupted in Padarayanapura on Sunday allegedly over the shifting of suspected COVID-19 persons to a quarantine facility by the Bruhat Bengaluru Mahanagara Palike (BBMP) officials.

The incident occurred in the late evening at Padarayanapura, which is recognized as a 'Red Zone', when BBMP officials went to shift 15 secondary contacts of corona positive patients. However, some people created a ruckus, broke the barricade and removed the police post in the area.

In Karnataka, 390 people have detected positive for COVID-19, of which 16 people have succumbed to the infection, as per the Union Health Ministry.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.